Sign-up for our newsletter
Protocols & Methods
Reagents & Resources
IMPC / KOMP Data
Function of Cryopreserved Mesenchymal Stromal Cells With and Without
Interferon-? Prelicensing is Context Dependent.
Burand AJ, Gramlich OW, Brown AJ, Ankrum JA
James Ankrum on 12/29/2016
Stem cells (Dayton, Ohio)
Volume : Pages
Tailoring MSCs to fit the disease. Fresh, cryopreserved and, prelicensed
cryopreserved MSC are all being explored to treat numerous diseases, but all are
not suitable to treat all conditions. injury. "*" denotes preferred therapeutic
strategy when both fresh MSC and cryo-MSC have shown utility in treating the
disease but one is more efficacious or logistically suitable., CLI, critical
limb ischemia; GvHD. graft versus host disease; I/R, ischemia reperfusion (I/R);
OI, osteogenesis imperfecta.
Investigators with authorship
University of Iowa
Neuropathy & Neurocognition
Welcome to the DiaComp Login / Account Request Page.
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
There was a problem with the page:
Safari Browser Detected...
We strive to make the DiaComp site compatable with as many browsers as possible, but some of our third party tools don't work with the Safari browser.
In order to explore this site we highly recommend using the most recent versions of the following browsers:
© 2018 DiaComp.org
All rights reserved
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!